Diabetes drug is linked with bladder cancer risk.
Rebecca
R
Voelker
D000368:Aged; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004348:Drug Labeling; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D000077205:Pioglitazone; D012306:Risk; D045162:Thiazolidinediones / Q000009:adverse effects* / Q000627:therapeutic use; D006113:United Kingdom / Q000453:epidemiology; D014481:United States; D014486:United States Food and Drug Administration; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone